HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7th at 9:00 am ET. A webcast of the presentation will be available on the “Events & Presentations” page of the “Investors & Media” section of the Celldex website. A replay will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.
Senior Vice President, Corporate Affairs & Administration
- Smart Speaker Market Accelerates at 32.5% CAGR to Reach US$ 110 Billion by 2033: Fact.MR Report - September 26, 2023
- Conference Room Solutions Market Surges to US$ 6,068.1 Million by 2033, Propelled by a Remarkable CAGR of 14.8% | Future Market Insights, Inc. - September 26, 2023
- HE SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Hawaiian Electric Industries, Inc. (HE) - September 26, 2023